Immune system of recovered COVID-19 patients may evolve to fight SARS-CoV-2 variants says study


PTI, Jan 24, 2021, 9:47 AM IST

New York: People who recover from COVID-19 are protected against the novel coronavirus for at least six months, and likely much longer, according to a study which says the immune system evolves long after the infection and may block even mutant forms of the virus such as the South African variant.

The research, published in the journal Nature, noted that antibodies are produced by immune cells that keep evolving, apparently due to continued exposure to remnants of the virus hidden in the gut tissue.

According to the scientists, including those from Rockefeller University in the US, the study provides the ”strongest evidence yet” that the immune system ”remembers” the virus and, remarkably, continues to improve the quality of antibodies even after the infection has waned. They suspect that when recovered patients next encounters the virus, the response would be both faster and more effective, preventing reinfection.

”This is really exciting news. The type of immune response we see here could potentially provide protection for quite some time, by enabling the body to mount a rapid and effective response to the virus upon re-exposure,” says Michel C. Nussenzweig, a co-author of the study from Rockefeller University.

While antibodies against the coronavirus linger in the blood plasma for several weeks or months, earlier studies have shown that their levels significantly drop with time.

However, the researchers showed that instead of producing antibodies all the time, the immune system creates memory B cells that recognise the coronavirus, and quickly unleash a new round of antibodies when they encounter it a second time.

Since the novel coronavirus replicates in the cells of the lungs, upper throat, and small intestine, they suspect that residual viral particles hiding within these tissues could be driving the evolution of memory B cells.

In the current study, the scientists studied the antibody responses of 87 individuals at two timepoints – one month after infection, and then again six months later.

Although antibodies were still detectable by the six-month point, their numbers had markedly decreased, with lab experiments revealing that the ability of the participants’ plasma samples to neutralise the virus was reduced by five-fold.

In contrast, the researchers found that the patients’ memory B cells – specifically those that produce antibodies against the coronavirus – did not decline in number. These cells also slightly increased in some cases, the study noted.

The scientists also discovered that the memory B cells had gone through numerous rounds of mutation even after the infection resolved. As a result, the antibodies they produced were much more effective than the originals, the study noted.

According to the researchers, these antibodies were better able to latch on tightly to the virus and could recognise even mutated versions of it.

”The overall numbers of memory B cells that produced antibodies attacking the Achilles’ heel of the virus, known as the receptor-binding domain, stayed the same,” said Christian Gaebler, another co-author of the study.

”That’s good news because those are the ones that you need if you encounter the virus again,” Gaebler said.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Manipal: Student killed in road mishap

5G set to speed up news delivery, improve quality of content: Thakur

At 295, Mumbai reports highest COVID-19 cases in over three months

Eye on 2024 Lok Sabha polls, BJP kick-starts booth strengthening campaign

Take action against corrupt ministers: AAP dares BJP in K’taka

Liquor to be costlier in Meghalaya as cabinet approves tax hike

Yasin Malik gets life imprisonment in terror funding case


Related Articles More

Active COVID-19 cases dip to 14,832

Active COVID-19 cases in country dip to 14,955

India sees single-day rise of 2,323 COVID-19 cases

Covid19: Active cases in country dip to 15,044

Biological E. cuts price of its COVID-19 vaccine to Rs 250 per dose

MUST WATCH

Manipal Road Mishap Student end his Life

NEWS BULLETIN 25-05-2022

Wheel Chair Romeo actor exclusive interview | RELEASING ON MAY 27TH

Snake Rescue Operation at Sirsi

No Ticket For BY Vijayendra In Karnataka MLC Polls; BS Yediyurappa Reacts


Latest Additions

Manipal: Student killed in road mishap

5G set to speed up news delivery, improve quality of content: Thakur

At 295, Mumbai reports highest COVID-19 cases in over three months

Eye on 2024 Lok Sabha polls, BJP kick-starts booth strengthening campaign

Court awarding life imprisonment to Yasin Malik a ‘setback’ to peace efforts: PAGD

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.